Literature DB >> 9284116

Disruption of each of the secreted aspartyl proteinase genes SAP1, SAP2, and SAP3 of Candida albicans attenuates virulence.

B Hube1, D Sanglard, F C Odds, D Hess, M Monod, W Schäfer, A J Brown, N A Gow.   

Abstract

Secreted aspartyl proteinases (Saps), encoded by a gene family with at least nine members (SAP1 to SAP9), are one of the most discussed virulence factors produced by the human pathogen Candida albicans. In order to study the role of each Sap isoenzyme in pathogenicity, we have constructed strains which harbor mutations at selected SAP genes. SAP1, SAP2, and SAP3, which are regulated differentially in vitro, were mutated by targeted gene disruption. The growth rates of all homozygous null mutants were similar to those of the isogenic wild-type parental strain (SC5314) in complex and defined media. In medium with protein as the sole source of nitrogen, sap1 and sap3 mutants grew with reduced growth rates but reached optical densities similar to those measured for SC5314. In contrast, sap2 null mutants tended to clump, grew poorly in this medium, and produced the lowest proteolytic activity. Addition of ammonium ions reversed such growth defects. These results support the view that Sap2 is the dominant isoenzyme. When sap1, sap2, and sap3 mutants were injected intravenously in guinea pigs and mice, the animals had increased survival rates compared to those of control animals infected with SC5314. However, reduction of proteolytic activity in vitro did not correlate directly with the extent of attenuation of virulence observed for all Sap-deficient mutants. These data suggest that SAP1, SAP2, and SAP3 all contribute to the overall virulence of C. albicans and presumably all play important roles during disseminated infections.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9284116      PMCID: PMC175503          DOI: 10.1128/iai.65.9.3529-3538.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  57 in total

1.  A synoptical approach to the diagnosis of candidosis, relying on serological antigen and antibody tests, on culture, and on evaluation of clinical data.

Authors:  R Rüchel; B Böning-Stutzer; A Mari
Journal:  Mycoses       Date:  1988-02       Impact factor: 4.377

2.  Integrative transformation of Candida albicans, using a cloned Candida ADE2 gene.

Authors:  M B Kurtz; M W Cortelyou; D R Kirsch
Journal:  Mol Cell Biol       Date:  1986-01       Impact factor: 4.272

3.  Genetic evidence for role of extracellular proteinase in virulence of Candida albicans.

Authors:  K J Kwon-Chung; D Lehman; C Good; P T Magee
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

4.  Correlative relationship between proteinase production, adherence and pathogenicity of various strains of Candida albicans.

Authors:  M Ghannoum; K Abu Elteen
Journal:  J Med Vet Mycol       Date:  1986-10

5.  Evidence for a correlation between proteinase secretion and vulvovaginal candidosis.

Authors:  A Cassone; F De Bernardis; F Mondello; T Ceddia; L Agatensi
Journal:  J Infect Dis       Date:  1987-11       Impact factor: 5.226

6.  Virulence of alkaline protease-deficient mutants of Aspergillus fumigatus.

Authors:  M Monod; S Paris; J Sarfati; K Jaton-Ogay; P Ave; J P Latgé
Journal:  FEMS Microbiol Lett       Date:  1993-01-01       Impact factor: 2.742

7.  Pathogenicity of morphological and auxotrophic mutants of Candida albicans in experimental infections.

Authors:  M G Shepherd
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

8.  Expression of extracellular acid proteinase by proteolytic Candida spp. during experimental infection of oral mucosa.

Authors:  M Borg; R Rüchel
Journal:  Infect Immun       Date:  1988-03       Impact factor: 3.441

9.  Immunoblotting analysis of sera from patients with candidal vaginitis and healthy females.

Authors:  A Ishiguro; M Homma; T Sukai; K Higashide; S Torii; K Tanaka
Journal:  J Med Vet Mycol       Date:  1992

10.  A positive selection for mutants lacking orotidine-5'-phosphate decarboxylase activity in yeast: 5-fluoro-orotic acid resistance.

Authors:  J D Boeke; F LaCroute; G R Fink
Journal:  Mol Gen Genet       Date:  1984
View more
  81 in total

1.  Misexpression of the opaque-phase-specific gene PEP1 (SAP1) in the white phase of Candida albicans confers increased virulence in a mouse model of cutaneous infection.

Authors:  C Kvaal; S A Lachke; T Srikantha; K Daniels; J McCoy; D R Soll
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

Review 2.  Strategies for the identification of virulence determinants in human pathogenic fungi.

Authors:  R Alonso-Monge; F Navarro-García; E Román; B Eisman; C Nombela; J Pla
Journal:  Curr Genet       Date:  2003-02-08       Impact factor: 3.886

3.  Loss of heterozygosity at an unlinked genomic locus is responsible for the phenotype of a Candida albicans sap4Δ sap5Δ sap6Δ mutant.

Authors:  Nico Dunkel; Joachim Morschhäuser
Journal:  Eukaryot Cell       Date:  2010-11-19

4.  In vivo analysis of secreted aspartyl proteinase expression in human oral candidiasis.

Authors:  J R Naglik; G Newport; T C White; L L Fernandes-Naglik; J S Greenspan; D Greenspan; S P Sweet; S J Challacombe; N Agabian
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

5.  Deletion of ADA2 Increases Antifungal Drug Susceptibility and Virulence in Candida glabrata.

Authors:  Shang-Jie Yu; Ya-Lin Chang; Ying-Lien Chen
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

6.  Divergence of Stp1 and Stp2 transcription factors in Candida albicans places virulence factors required for proper nutrient acquisition under amino acid control.

Authors:  Paula Martínez; Per O Ljungdahl
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

7.  Relationship between Candida albicans virulence during experimental hematogenously disseminated infection and endothelial cell damage in vitro.

Authors:  Angela A Sanchez; Douglas A Johnston; Carter Myers; John E Edwards; Aaron P Mitchell; Scott G Filler
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

8.  Candida albicans VPS4 contributes differentially to epithelial and mucosal pathogenesis.

Authors:  Hallie S Rane; Sarah Hardison; Claudia Botelho; Stella M Bernardo; Floyd Wormley; Samuel A Lee
Journal:  Virulence       Date:  2014-10-31       Impact factor: 5.882

9.  Candida albicans VPS4 is required for secretion of aspartyl proteases and in vivo virulence.

Authors:  Samuel A Lee; Jason Jones; Sarah Hardison; John Kot; Zachary Khalique; Stella M Bernardo; Anna Lazzell; Carlos Monteagudo; Jose Lopez-Ribot
Journal:  Mycopathologia       Date:  2008-09-24       Impact factor: 2.574

10.  An Opaque Cell-Specific Expression Program of Secreted Proteases and Transporters Allows Cell-Type Cooperation in Candida albicans.

Authors:  Matthew B Lohse; Lucas R Brenes; Naomi Ziv; Michael B Winter; Charles S Craik; Alexander D Johnson
Journal:  Genetics       Date:  2020-08-24       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.